Comprehensive Assessment of Quality of Life, Functioning, and Mental Health in Children With Juvenile Idiopathic Arthritis and Noninfectious Uveitis

Objective Pediatric uveitis can lead to sight‐threatening complications and can impact quality of life (QoL) and functioning. We aimed to examine health‐related QoL, mental health, physical disability, vision‐related functioning (VRF), and vision‐related QoL in children with juvenile idiopathic arth...

Full description

Saved in:
Bibliographic Details
Published inArthritis care & research (2010) Vol. 74; no. 8; pp. 1311 - 1320
Main Authors McDonald, Joseph, Cassedy, Amy, Altaye, Mekibib, Andringa, Jennifer, Cooper, Ashley M., Drews‐Botsch, Carolyn, Engelhard, George, Hennard, Theresa, Holland, Gary N., Jenkins, Kirsten, Lambert, Scott R., Lipscomb, Jessi, McCracken, Courtney, McCurdy, Deborah K., Mwase, Najima, Prahalad, Sampath, Shantha, Jessica, Stahl, Erin, Utz, Virginia Miraldi, Walker, A. Adrienne, Yeh, Steven, Angeles‐Han, Sheila T.
Format Journal Article
LanguageEnglish
Published Boston, USA Wiley Periodicals, Inc 01.08.2022
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective Pediatric uveitis can lead to sight‐threatening complications and can impact quality of life (QoL) and functioning. We aimed to examine health‐related QoL, mental health, physical disability, vision‐related functioning (VRF), and vision‐related QoL in children with juvenile idiopathic arthritis (JIA), JIA‐associated uveitis (JIA‐U), and other noninfectious uveitis. We hypothesized that there will be differences based on the presence of eye disease. Methods A multicenter cross‐sectional study was conducted at four sites. Patients with JIA, JIA‐U, or noninfectious uveitis were enrolled. Patients and parents completed the Pediatric Quality of Life Inventory (PedsQL; health‐related QoL), the Revised Childhood Anxiety and Depression Scale (RCADS; anxiety/depression), the Childhood Health Assessment Questionnaire (C‐HAQ; physical disability), and the Effects of Youngsters' Eyesight on Quality of Life (EYE‐Q) (VRF/vision‐related QoL). Clinical characteristics and patient‐reported outcome measures were compared by diagnosis. Results Of 549 patients, 332 had JIA, 124 had JIA‐U, and 93 had other uveitis diagnoses. Children with JIA‐U had worse EYE‐Q scores compared to those with JIA only. In children with uveitis, those with anterior uveitis (JIA‐U and uveitis only) had less ocular complications, better EYE‐Q scores, and worse C‐HAQ and PedsQL physical summary scores compared to those with nonanterior disease. In children with anterior uveitis, those with JIA‐U had worse PedsQL physical summary and C‐HAQ scores than anterior uveitis only. Further, EYE‐Q scores were worse in children with bilateral uveitis and more visual impairment. There were no differences in RCADS scores among groups. Conclusion We provide a comprehensive outcome assessment of children with JIA, JIA‐U, and other uveitis diagnoses. Differences in QoL and function were noted based on underlying disease. Our results support the addition of a vision‐specific measure to better understand the impact of uveitis.
Bibliography:This study and Dr. Angeles‐Han's work were supported by the NIH/National Eye Institute (grants K‐23‐EY‐021760 and R01EY030521), the Rheumatology Research Foundation, the Childhood Arthritis and Rheumatology Research Alliance, the Arthritis Foundation, the Weill Cornell Medical College Clinical and Translational Science Center (grant UL1‐RR‐024996), Emory Egleston Children's Research Center, and the Knights Templar Eye Foundation. Also supported by the NIH/National Center for Advancing Translational Sciences (grant UL‐1TR‐000077).
No potential conflicts of interest relevant to this article were reported.
The content herein is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2151-464X
2151-4658
DOI:10.1002/acr.24551